Efficacy of Pitolisant 20 mg in Reducing Excessive Daytime Sleepiness and Fatigue in Patients with Obstructive Sleep Apnoea Syndrome: An Individual Patient Data Meta-analysis

BACKGROUND AND OBJECTIVE: Excessive daytime sleepiness (EDS) and fatigue are major complaints in patients with obstructive sleep apnoea (OSA) syndrome. Pitolisant is an orally active selective histamine H3 receptor (H3R) antagonist/inverse agonist, which enhances histaminergic transmissions in the b...

Descripción completa

Detalles Bibliográficos
Autor principal: Lehert, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755655/
https://www.ncbi.nlm.nih.gov/pubmed/34859394
http://dx.doi.org/10.1007/s40261-021-01104-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755655/
https://www.ncbi.nlm.nih.gov/pubmed/34859394
http://dx.doi.org/10.1007/s40261-021-01104-8

Ejemplares similares